Justin Chokmah
Chief Business Officer
Replay available
ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Q1 2026 earnings conference call, held 2026-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Richard Lowenthal
Co-founder, President & CEO
Eric Karras
Chief Commercial Officer
Kathy Scott
Chief Financial Officer
Rowana Ruiz
Analyst, Lyric Partners
Lachlan Hanbury Brown
Analyst, William Blair
Ryan Dreschner
Analyst, Raymond James
Josh Zimmer
Analyst, Cantor
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ars Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.895 Good morning and welcome to ARS Pharmaceuticals' first quarter 2026 earnings conference 00:00:03.895 -- 00:00:07.338 call. At this time, all participants are in a listen-only mode. 00:00:07.338 -- 00:00:10.281 After the company's prepared remarks, we'll open the line for questions. 00:00:10.281 -- 00:00:12.904 Please be advised that today's conference is being recorded. 00:00:12.904 -- 00:00:15.487 I will now turn the call over to Justin Chokmah, Chief Business Officer. 00:00:15.487 -- 00:00:17.847 Please go ahead. 00:00:19.611 -- 00:00:24.796 Good morning and thank you for joining our first quarter 2026 earnings conference call. 00:00:24.796 -- 00:00:30.290 With me on the call are Richard Lowenthal, our co-founder, president, and CEO, Eric Karras, 00:00:30.290 -- 00:00:35.557 our Chief Commercial Officer, and Kathy Scott, our Chief Financial Officer. 00:00:35.557 -- 00:00:39.802 Earlier this morning, we issued a press release detailing our financial results and commercial 00:00:39.802 -- 00:00:43.687 highlights for the first quarter of 2026. That 00:00:43.687 -- 00:00:48.213 press release and our slide presentation are available in the Investors and Media section 00:00:48.213 -- 00:00:49.895 of our website. 00:00:49.895 -- 00:00:55.162 Before we begin, please note that today's remarks may contain forward-looking statements. 00:00:55.162 -- 00:01:00.426 Actual results may differ materially. please refer to our press release and SEC filings 00:01:00.426 -- 00:01:02.829 for further risk disclosures. 00:01:02.829 -- 00:01:06.531 With that, I'll turn the call over to Rich. 00:01:06.975 -- 00:01:11.901 Thank you, Justin, and good morning, everybody, and thank you for joining us on the call. 00:01:11.901 -- 00:01:17.028 We are off to a s...